BEAM
NASDAQ
US
Beam Therapeutics Inc. - Common Stock
$24.66
▲ +$0.44
(+1.82%)
Vol 1.9M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$2.8B
ROE
-42.9%
Margin
-744.4%
D/E
0.00
Beta
2.13
52W
$14–$35
Wall Street Consensus
25 analysts · Apr 202611
Strong Buy
11
Buy
3
Hold
0
Sell
0
Strong Sell
88.0%
Buy Rating
Price Chart
Similar Stocks
IDYA
IDEAYA Biosciences Inc
$3.0B
TVTX
Travere Therapeutics Inc
$3.4B
ORKA
Oruka Therapeutics Inc
$1.5B
VCYT
Veracyte Inc
P/E 110.3
$3.3B
IRON
Disc Medicine Inc
$3.0B
KOD
Kodiak Sciences Inc
$1.7B
IMNM
Immunome Inc
$2.4B
SRPT
Sarepta Therapeutics Inc
$2.3B
BCRX
BioCryst Pharmaceuticals Inc
$1.6B
GRAL
Grail Inc
$3.3B
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-1.01 | $-0.10 | +$0.91 |
| Sep 2025 | $-1.06 | $-1.10 | $-0.04 |
| Jun 2025 | $-1.13 | $-1.00 | +$0.13 |
| Mar 2025 | $-1.23 | $-1.24 | $-0.01 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -43.1% | -43.1% | -43.1% | -43.1% | -42.9% | -42.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1208.3% | -661.3% | -661.3% | -661.3% | -744.4% | -744.4% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.75 | 6.75 | 6.75 | 6.75 | 6.02 | 6.02 |
Key Ratios
ROA (TTM)
-31.5%
P/S (TTM)
50.50
P/B
2.8
EPS (TTM)
$-4.43
CF/Share
$-3.96
Rev Growth 3Y
+7.0%
52W High
$35.25
52W Low
$13.53
$13.53
52-Week Range
$35.25
How does BEAM compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BEAM valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
50.5
▲
293%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
2.8
▲
14%
above
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BEAM profitability vs Biotechnology peers
ROE
-42.9%
▲
36%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-744.4%
▼
160%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-31.5%
▲
33%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
BEAM financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.0
▲
36%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
2.1
▲
119%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
BEAM fundamentals radar
BEAM
Peer median
Industry
BEAM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BEAM vs peers: key metrics
Latest News
No related news yet